Product image of Gemgerta (Brivaracetam) supplied by GNH India

Gemgerta

Active Ingredient:
Brivaracetam
Origin:
EU

Gemgerta (Brivaracetam)

Gemgerta is an oral medication containing Brivaracetam, used to manage certain neurological conditions. This prescription drug is manufactured by Zentiva, K.S., and is available in the EU market.

Manufacturer / TM Owner

Zentiva, K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Gemgerta is primarily used as an adjunctive therapy for the treatment of partial-onset seizures in adults and children. It works by affecting certain chemicals in the brain that may be involved in causing seizures. The medication is designed to help control seizures but does not cure the underlying condition.

Side Effects

  • Common effects of Gemgerta may include dizziness, fatigue, and nausea. Some users might experience somnolence or irritability. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

  • Gemgerta should be handled with care, especially by individuals with a history of psychiatric disorders or substance abuse. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the medication in a safe place, out of reach of children and pets.

Avoid Interactions

  • Gemgerta may interact with other medications, including those that affect the central nervous system. It is crucial to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with Gemgerta, so it is advisable to discuss their use with a healthcare professional.

Frequently Asked Questions

Gemgerta is used as an adjunctive therapy for the treatment of partial-onset seizures in adults and children.

Gemgerta is taken orally, and the specific dosage and administration instructions should be followed as prescribed by a healthcare provider.

Common side effects of Gemgerta may include dizziness, fatigue, nausea, somnolence, and irritability.

Gemgerta may interact with other medications, so it is important to inform your healthcare provider about all the medications you are taking.

Gemgerta is approved for use in children for the treatment of partial-onset seizures, but it should be administered under the supervision of a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Brivaracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT